Pancreatic Cancer: From Genes to Patient Care

Journal of Gastrointestinal Surgery

Volumn 5, Issue 6, 2001, Pages 583-587

  Hruban, Ralph H ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE;

CANCER STAGING; FEMALE; GENETIC PREDISPOSITION; GENETICS; HUMAN; MALE; MASS SCREENING; METHODOLOGY; MORTALITY; MULTIMODALITY CANCER THERAPY; PANCREAS RESECTION; PANCREAS TUMOR; PATHOLOGY; PROGNOSIS; REVIEW; SURVIVAL; TREATMENT OUTCOME;

CANCER VACCINES; COMBINED MODALITY THERAPY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MASS SCREENING; NEOPLASM STAGING; PANCREATECTOMY; PANCREATIC NEOPLASMS; PROGNOSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0035502429     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1091-255X(01)80099-8     Document Type: Article

References (13)

1. Schulick RD, Yeo CJ. Whipple procedure: 1935 to present. In Evans DB, Pisters PW, Abbruzzese JL, eds. M.D. Anderson Solid Tumor Series. New York: Springer-Verlag.
2. Yeo CJ, Cameron JL, Lillemoe KD, Sitzmann JV, Hruban RH, Goodman SN, Dooley WC, Coleman J, Pitt HA. Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg 1995;221:721-733.
3. Yeo CJ, Cameron JL, Sohn TA, Coleman J, Sauter PK, Hruban RH, Pitt HA, Lillemoe KD. Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: Comparison of morbidity and mortality and short-term outcome. Ann Surg 1999;229:613-622.
4. Yeo CJ, Sohn TA, Cameron JL, Hruban RH, Lillemoe KD, Pitt HA. Periampullary adenocarcinoma: Analysis of 5-year survivors [see comments]. Ann Surg 1998;227:821-831.
5. Niederhuber JE, Brennan MF, Menck HR. The national cancer data base report on pancreatic cancer. Cancer 1995;76: 1671-1677.
6. Allison DC, Piantadosi S, Hruban RH, Dooley WC, Fishman E, Lin P, Cameron JL. DNA content and other factors associated with ten-year survival after resection of pancreatic carcinoma. J Surg Oncol 1998;67:151-159.
7. Tersmette AC, Petersen GM, Offerhaus GJA, Falatko FC, Goggins M, Rosenblum E, Wilentz RE, Yeo CJ, Cameron JL, Kern SE, Hruban RH. Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. Clin Cancer Res 2001;7:738-744.
8. Ueki T, Toyota M, Sohn TA, Yeo CJ, Issa J-PJ, Hruban RH, Goggins M. Hypermethylation of multiple genes in pancreatic carcinoma. Cancer Res 2000;60:1835-1839.
9. Palmisano WA, Divine KK, Saccomanno G, Gilliland FD, Baylin SB, Herman JG, Belinsky SA. Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res 2000;60:5954-5958.
10. Zhang L, Zhou W, Velculescu VE, Kern SE, Hruban RH, Hamilton SR, Vogelstein B, Kinzler KW. Gene expression profiles in normal and cancer cells. Science 1997;276:1268-1272.
11. Zhou W, Sokoll LJ, Bruzek DJ, Zhang L, Velculescu VE, Goldin SB, Hruban RH, Kern SE, Hamilton SR, Chan DW, Vogelstein B, Kinzler KW. Identifying markers for pancreatic cancer by gene expression analysis. Cancer Epidemiol Biomarkers Prev 1998;7:109-112.
12. Hruban RH, Goggins M, Parsons JL, Kern SE. Progression model for pancreatic cancer. Clin Cancer Res 2000;6:2969-2972.
13. Jaffee EM, Hruban RH, Biedrzycki B, Laheru D, Schepers K, Sauter PR, Goemann M, Coleman J, Grochow L, Donehower RC, Lillemoe KD, O'Reilly S, Abrams RA, Pardoll DM, Cameron JL, Yeo CJ. Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: A phase I trial of safety and immune activation. J Clin Oncol 2001;19:145-156.